These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 9722935)

  • 1. Soluble interleukin 6 (IL-6) receptor influences the expression of the protooncogene junB and the production of fibrinogen in the HepG2 human hepatoma cell line and primary rat hepatocytes.
    Igaz P; Tóth S; Rose-John S; Madurka I; Fejér G; Szalai C; Falus A
    Cytokine; 1998 Aug; 10(8):620-6. PubMed ID: 9722935
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Soluble interleukin-6 receptor strongly increases the production of acute-phase protein by hepatoma cells but exerts minimal changes on human primary hepatocytes.
    Gabay C; Silacci P; Genin B; Mentha G; Le Coultre C; Guerne PA
    Eur J Immunol; 1995 Aug; 25(8):2378-83. PubMed ID: 7545121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors influencing the effect of the soluble IL-6 receptor on IL-6 responses in HepG2 hepatocytes.
    Paysant J; Blanqué R; Vasse M; Soria C; Soria J; Gardner CR
    Cytokine; 2000 Jun; 12(6):774-9. PubMed ID: 10843763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. gp130-specific antisense oligonucleotides inhibit IL-6 signal inducing junB mRNA transcription in the human hepatoma cell line, HepG2.
    Varga VL; Fülöp AK; Holub MC; Tóth S; Szalai C; Falus A
    Cell Biol Int; 2001; 25(8):835-40. PubMed ID: 11482910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo and in vitro activities of the gp130-stimulating designer cytokine Hyper-IL-6.
    Peters M; Blinn G; Solem F; Fischer M; Meyer zum Büschenfelde KH; Rose-John S
    J Immunol; 1998 Oct; 161(7):3575-81. PubMed ID: 9759879
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Soluble interleukin-6 receptor alpha inhibits the cytokine-Induced fractalkine/CX3CL1 expression in human vascular endothelial cells in culture.
    Matsumiya T; Imaizumi T; Fujimoto K; Cui X; Shibata T; Tamo W; Kumagai M; Tanji K; Yoshida H; Kimura H; Satoh K
    Exp Cell Res; 2001 Sep; 269(1):35-41. PubMed ID: 11525637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. C-terminal peptides of interleukin-6 modulate the expression of junB protooncogene and the production of fibrinogen by HepG2 cells.
    Igaz P; Bösze S; Tóth S; Falus A; Hudecz F
    Biol Chem; 2001 Apr; 382(4):669-76. PubMed ID: 11405230
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Interleukin-6 acts in different ways via soluble and membrane-bound receptors].
    Igaz P; Tóth S; Madurka I; Falus A
    Orv Hetil; 1998 Jul; 139(29):1741-4. PubMed ID: 9715090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin-6 N-terminal peptides modulate the expression of junB protooncogene and the production of fibrinogen in HepG2 cells.
    Bosze S; Hudecz F; Igaz P; Ortutay Z; Csík G; Falus A; Tóth S
    Biol Chem; 2003 Mar; 384(3):409-21. PubMed ID: 12715892
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oncostatin M stimulates the expression and release of the IL-6 receptor in human hepatoma HepG2 cells.
    Cichy J; Rose-John S; Potempa J; Pryjma J; Travis J
    J Immunol; 1997 Dec; 159(11):5648-53. PubMed ID: 9548508
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Soluble IL-6 receptor potentiates the antagonistic activity of soluble gp130 on IL-6 responses.
    Müller-Newen G; Küster A; Hemmann U; Keul R; Horsten U; Martens A; Graeve L; Wijdenes J; Heinrich PC
    J Immunol; 1998 Dec; 161(11):6347-55. PubMed ID: 9834125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of IL-6 and the soluble IL-6 receptor in inhibition of VCAM-1 gene expression.
    Oh JW; Van Wagoner NJ; Rose-John S; Benveniste EN
    J Immunol; 1998 Nov; 161(9):4992-9. PubMed ID: 9794436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytokines oncostatin M and interleukin 1 regulate the expression of the IL-6 receptor (gp80, gp130).
    Geisterfer M; Richards CD; Gauldie J
    Cytokine; 1995 Aug; 7(6):503-9. PubMed ID: 8580365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin-6 biology is coordinated by membrane-bound and soluble receptors: role in inflammation and cancer.
    Rose-John S; Scheller J; Elson G; Jones SA
    J Leukoc Biol; 2006 Aug; 80(2):227-36. PubMed ID: 16707558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Major role of the soluble interleukin-6/interleukin-6 receptor complex for the proliferation of interleukin-6-dependent human myeloma cell lines.
    Gaillard JP; Liautard J; Klein B; Brochier J
    Eur J Immunol; 1997 Dec; 27(12):3332-40. PubMed ID: 9464821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Soluble IL-6 receptor leads to a paracrine modulation of the IL-6-induced hepatic acute phase response in double transgenic mice.
    Peters M; Odenthal M; Schirmacher P; Blessing M; Fattori E; Ciliberto G; Meyer zum Buschenfelde KH; Rose-John S
    J Immunol; 1997 Aug; 159(3):1474-81. PubMed ID: 9233646
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin-6-induced production of type II acute phase proteins and expression of junB gene are downregulated by human recombinant growth hormone in vitro.
    Derfalvi B; Igaz P; Fulop KA; Szalai C; Falus A
    Cell Biol Int; 2000; 24(2):109-14. PubMed ID: 10772770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel role of IL-6/SIL-6R signaling in the expression of inducible nitric oxide synthase (iNOS) in murine B16, metastatic melanoma clone F10.9, cells.
    Kang KW; Wagley Y; Kim HW; Pokharel YR; Chung YY; Chang IY; Kim JJ; Moon JS; Kim YK; Nah SY; Kang HS; Oh JW
    Free Radic Biol Med; 2007 Jan; 42(2):215-27. PubMed ID: 17189827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin-6 receptor signaling. II. Bio-availability of interleukin-6 in serum.
    Gaillard J; Pugnière M; Tresca J; Mani J; Klein B; Brochier J
    Eur Cytokine Netw; 1999 Sep; 10(3):337-44. PubMed ID: 10477390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complex of the soluble IL-11 receptor and IL-11 acts as IL-6-type cytokine in hepatic and nonhepatic cells.
    Baumann H; Wang Y; Morella KK; Lai CF; Dams H; Hilton DJ; Hawley RG; Mackiewicz A
    J Immunol; 1996 Jul; 157(1):284-90. PubMed ID: 8683127
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.